Product Details for: Cimerli

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravitreal
10MG/ML (0.5MG/0.05ML)
Single-Dose Vial
351(k) Interchangeable
Cimerli
Rx
002
Injection
Intravitreal
6MG/ML (0.3MG/0.05ML)
Single-Dose Vial
351(k) Interchangeable
Cimerli
Rx
Proper Name
ranibizumab-eqrn
Reference Product Proper Name
ranibizumab
Reference Product Properietary Name
Lucentis
BLA Number
761165
Applicant
Sandoz Inc.
Original Approval Date
August 2, 2022
Date of First Licensure
RETURN TO SEARCH RESULTS